跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AKLIEF - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
AKLIEF
Authorized
STANDARD
AKLIEF
galderma canada inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
d87c004c8c6bcb4f
Company
galderma canada inc
Type
Standard
Approval Details
Approval Id
d87c004c8c6bcb4f
Drug Approval Canada Name
AKLIEF
Product Name
AKLIEF
Status
Marketed
Status Date
2019-11-28
Original Market Date
2019-11-28
Din
02494175
Drug Class
Human
Dosage Form
Cream
Route Of Administration
Topical
Schedule
Prescription
Ahfs
84:92.00
Atc Original
D10AD06 TRIFAROTENE
Atc Name
d 10 ad 06
Aig Number
0161970001
Company Name
galderma canada inc
Company Address
SUITE 400, 55 Commerce Valley Drive West, Thornhill, Ontario, Canada, L3T 7V9
Active Ingredients
TRIFAROTENE
50 MCG / G
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
d87c004c8c6bcb4f
Type
Standard
Back to Health Canada Approvals